Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.

Capasso M, Diskin SJ, Totaro F, Longo L, De Mariano M, Russo R, Cimmino F, Hakonarson H, Tonini GP, Devoto M, Maris JM, Iolascon A.

Carcinogenesis. 2013 Mar;34(3):605-11. doi: 10.1093/carcin/bgs380. Epub 2012 Dec 7. Erratum in: Carcinogenesis. 2014 Mar;35(3):737.

2.

The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.

Zhang R, Zou Y, Zhu J, Zeng X, Yang T, Wang F, He J, Xia H.

Int J Med Sci. 2016 Feb 3;13(2):133-8. doi: 10.7150/ijms.13426. eCollection 2016.

3.

Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.

Latorre V, Diskin SJ, Diamond MA, Zhang H, Hakonarson H, Maris JM, Devoto M.

Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):658-63. doi: 10.1158/1055-9965.EPI-11-0830. Epub 2012 Feb 10.

4.

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.

Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner JT, Attiyeh EF, Mosse YP, Kim C, Diskin SJ, Cole KA, Bosse K, Diamond M, Laudenslager M, Winter C, Bradfield JP, Scott RH, Jagannathan J, Garris M, McConville C, London WB, Seeger RC, Grant SF, Li H, Rahman N, Rappaport E, Hakonarson H, Maris JM.

Nat Genet. 2009 Jun;41(6):718-23. doi: 10.1038/ng.374. Epub 2009 May 3.

5.

Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.

Nguyen le B, Diskin SJ, Capasso M, Wang K, Diamond MA, Glessner J, Kim C, Attiyeh EF, Mosse YP, Cole K, Iolascon A, Devoto M, Hakonarson H, Li HK, Maris JM.

PLoS Genet. 2011 Mar;7(3):e1002026. doi: 10.1371/journal.pgen.1002026. Epub 2011 Mar 17.

6.

BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.

Fu W, Zhu J, Xiong SW, Jia W, Zhao Z, Zhu SB, Hu JH, Wang FH, Xia H, He J, Liu GC.

EBioMedicine. 2017 Feb;16:101-105. doi: 10.1016/j.ebiom.2017.01.038. Epub 2017 Jan 31.

7.

Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1.

Lu J, Chu P, Wang H, Jin Y, Han S, Han W, Tai J, Guo Y, Ni X.

PLoS One. 2015 Jun 1;10(6):e0127856. doi: 10.1371/journal.pone.0127856. eCollection 2015.

8.

Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.

Totaro F, Cimmino F, Pignataro P, Acierno G, De Mariano M, Longo L, Tonini GP, Iolascon A, Capasso M.

PLoS One. 2013 Oct 21;8(10):e76810. doi: 10.1371/journal.pone.0076810. eCollection 2013.

9.

Common genetic variants in NEFL influence gene expression and neuroblastoma risk.

Capasso M, Diskin S, Cimmino F, Acierno G, Totaro F, Petrosino G, Pezone L, Diamond M, McDaniel L, Hakonarson H, Iolascon A, Devoto M, Maris JM.

Cancer Res. 2014 Dec 1;74(23):6913-24. doi: 10.1158/0008-5472.CAN-14-0431. Epub 2014 Oct 13.

10.

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.

Diskin SJ, Capasso M, Schnepp RW, Cole KA, Attiyeh EF, Hou C, Diamond M, Carpenter EL, Winter C, Lee H, Jagannathan J, Latorre V, Iolascon A, Hakonarson H, Devoto M, Maris JM.

Nat Genet. 2012 Oct;44(10):1126-30. doi: 10.1038/ng.2387. Epub 2012 Sep 2.

11.

The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population.

Gonzalez-Hormazabal P, Reyes JM, Blanco R, Bravo T, Carrera I, Peralta O, Gomez F, Waugh E, Margarit S, Ibañez G, Santos JL, Jara L.

Mol Biol Rep. 2012 Aug;39(8):8091-8. doi: 10.1007/s11033-012-1656-2. Epub 2012 Apr 28.

PMID:
22544576
12.

Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.

Huo X, Hu Z, Zhai X, Wang Y, Wang S, Wang X, Qin J, Chen W, Jin G, Liu J, Gao J, Wei Q, Wang X, Shen H.

Breast Cancer Res Treat. 2007 May;102(3):329-37. Epub 2006 Sep 21.

PMID:
17028982
13.

Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

Bosse KR, Diskin SJ, Cole KA, Wood AC, Schnepp RW, Norris G, Nguyen le B, Jagannathan J, Laquaglia M, Winter C, Diamond M, Hou C, Attiyeh EF, Mosse YP, Pineros V, Dizin E, Zhang Y, Asgharzadeh S, Seeger RC, Capasso M, Pawel BR, Devoto M, Hakonarson H, Rappaport EF, Irminger-Finger I, Maris JM.

Cancer Res. 2012 Apr 15;72(8):2068-78. doi: 10.1158/0008-5472.CAN-11-3703. Epub 2012 Feb 20.

14.

Single nucleotide polymorphism rs11669203 in TGFBR3L is associated with the risk of neuroblastoma in a Chinese population.

Jin Y, Wang H, Han W, Lu J, Chu P, Han S, Ni X, Ning B, Yu D, Guo Y.

Tumour Biol. 2016 Mar;37(3):3739-47. doi: 10.1007/s13277-015-4192-6. Epub 2015 Oct 14.

PMID:
26468016
15.

The BARD1 Cys557Ser variant and breast cancer risk in Iceland.

Stacey SN, Sulem P, Johannsson OT, Helgason A, Gudmundsson J, Kostic JP, Kristjansson K, Jonsdottir T, Sigurdsson H, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Bergthorsson JT, Amundadottir LT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.

PLoS Med. 2006 Jul;3(7):e217.

16.

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.

Noth I, Zhang Y, Ma SF, Flores C, Barber M, Huang Y, Broderick SM, Wade MS, Hysi P, Scuirba J, Richards TJ, Juan-Guardela BM, Vij R, Han MK, Martinez FJ, Kossen K, Seiwert SD, Christie JD, Nicolae D, Kaminski N, Garcia JG.

Lancet Respir Med. 2013 Jun;1(4):309-17. doi: 10.1016/S2213-2600(13)70045-6. Epub 2013 Apr 17.

17.

[Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].

Sun G, Wang JT, Ma BL, Geng ZL, Ren GH, Shan MH, Ma B, Ma LL, Wang Y.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):341-7. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.005. Chinese.

PMID:
22883453
18.

Integrative genomics identifies LMO1 as a neuroblastoma oncogene.

Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, Schnepp RW, Diamond M, Bosse K, Mayes PA, Glessner J, Kim C, Frackelton E, Garris M, Wang Q, Glaberson W, Chiavacci R, Nguyen L, Jagannathan J, Saeki N, Sasaki H, Grant SF, Iolascon A, Mosse YP, Cole KA, Li H, Devoto M, McGrady PW, London WB, Capasso M, Rahman N, Hakonarson H, Maris JM.

Nature. 2011 Jan 13;469(7329):216-20. doi: 10.1038/nature09609. Epub 2010 Dec 1.

19.

Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.

Guénard F, Labrie Y, Ouellette G, Beauparlant CJ, Durocher F; INHERIT BRCAs.

J Hum Genet. 2009 Mar;54(3):152-61. doi: 10.1038/jhg.2009.6. Epub 2009 Feb 6.

PMID:
19197335
20.

Genome-wide pathway analysis in neuroblastoma.

Lee YH, Kim JH, Song GG.

Tumour Biol. 2014 Apr;35(4):3471-85. doi: 10.1007/s13277-013-1459-7. Epub 2013 Nov 30.

PMID:
24293394

Supplemental Content

Support Center